TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $761,000 | -12.8% | 55,840 | +4.7% | 0.01% | -20.0% |
Q3 2021 | $873,000 | -0.8% | 53,311 | +2.0% | 0.01% | -9.1% |
Q2 2021 | $880,000 | -4.6% | 52,262 | +4.0% | 0.01% | -8.3% |
Q1 2021 | $922,000 | -4.7% | 50,233 | -5.5% | 0.01% | -7.7% |
Q4 2020 | $967,000 | -9.3% | 53,156 | -9.0% | 0.01% | -23.5% |
Q3 2020 | $1,066,000 | -5.2% | 58,403 | -5.9% | 0.02% | -5.6% |
Q2 2020 | $1,124,000 | +8.0% | 62,082 | -6.7% | 0.02% | -5.3% |
Q1 2020 | $1,041,000 | -46.8% | 66,575 | -32.9% | 0.02% | -38.7% |
Q4 2019 | $1,958,000 | +8.8% | 99,290 | -5.0% | 0.03% | +3.3% |
Q3 2019 | $1,800,000 | -8.3% | 104,498 | -5.8% | 0.03% | -6.2% |
Q2 2019 | $1,963,000 | -19.1% | 110,908 | -6.9% | 0.03% | -23.8% |
Q1 2019 | $2,426,000 | – | 119,093 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Adelphi Capital LLP | 7,584,930 | $138,046,000 | 26.79% |
Glenview Capital Management | 15,260,512 | $277,741,000 | 6.37% |
Paulson & Co. | 11,295,846 | $205,584,000 | 5.34% |
GMT CAPITAL CORP | 2,871,395 | $52,259,000 | 3.72% |
MANAGED ASSET PORTFOLIOS, LLC | 966,643 | $17,593,000 | 3.09% |
TFG Asset Management GP Ltd | 1,443,052 | $26,264,000 | 1.76% |
Mondrian Investment Partners LTD | 3,274,660 | $58,944,000 | 1.46% |
Blackcrane Capital, LLC | 35,236 | $641,000 | 1.26% |
Lumbard & Kellner, LLC | 136,378 | $2,404,000 | 0.95% |
DAVIDSON INVESTMENT ADVISORS | 509,800 | $9,278,000 | 0.86% |